Takeda has announced the appointment of Ebru Yavuz as CEO of the newly formed Ukraine and CIS cluster. Thus, this merger forms the Cluster of Ukraine and the CIS (Commonwealth of Independent States), which includes: Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Uzbekistan and Ukraine. Ebru Yavuz has over 20 years of experience and extensive operational knowledge in the pharmaceutical industry, industry regulatory and senior strategic leadership experience. Ebru Yavuz joined Takeda in February 2016 as Head of Business Operations at Takeda Pharmaceuticals for ICMEA (India, CIS, Middle East, Turkey and Africa), developing a business strategy to grow, improve and optimize the company business operations.